- FESOTERODINE FUMARATE
[作者：Gomelsky, A; Dmochowski, RR,期刊：Drugs of today, 页码：81-90 , 文章类型： Article，,卷期：2010年46-2]
- Overactive bladder (CA B) is a common condition that causes a profound impact on an individual's overall health and quality of life. Muscarinic antagonists are the mainstay of oral pharmacotherapy for CAB. The most-recen...
- PRALATREXATE - FROM BENCH TO BEDSIDE
[作者：Zain, JM; Marchi, E,期刊：Drugs of today, 页码：91-99 , 文章类型： Article，,卷期：2010年46-2]
- Pralatrexate (PDX, 10-propargyl 10-deazaaminopterin) is an exciting new chemotherapeutic agent with promising activity in T-cell lymphomas and non-small cell lung cancer. It has been granted approval by the Food and Drug...
- SAXAGLIPTIN IN TYPE 2 DIABETES
[作者：Billones, R,期刊：Drugs of today, 页码：101-108 , 文章类型： Article，,卷期：2010年46-2]
- Saxagliptin is the latest addition to incretin-based therapies in the management of type? diabetes. The oral selective dipeptidyl peptidase 4 (DPP-4) inhibitor is just the second in its class to be approved in the U.S. I...
- EFFICACY AND SAFETY OF BIOLOGICALS AGAINST IMMUNE-MEDIATED DISEASES: DO BENEFITS OUTWEIGH RISKS?
[作者：Korkina, L; Trakhtman, P; De Luca, C; Leani, L; Raskovic, D; Pastore, S,期刊：Drugs of today, 页码：119-136 , 文章类型： Review，,卷期：2010年46-2]
- The success of molecular biology in identifying molecular pathways underlying chronic immune-mediated diseases and the rapid development of gene/cell engineering biotechnologies has resulted in the development of a numbe...
- TECOVIRIMAT FOR SMALLPOX INFECTIONS
[作者：Bolken, TC; Hruby, DE,期刊：Drugs of today, 页码：109-117 , 文章类型： Article，,卷期：2010年46-2]
- SIGA Technologies, Inc. is a small biotech company committed to developing novel products for the prevention and treatment of serious viral diseases, with an emphasis on products to combat outbreaks that could result fro...
|